Nancy S. Lurker

EyePoint Pharmaceuticals

Nancy Lurker brings to her roles as President, CEO and Director of Eyepoint Pharmaceuticals broad-based experience as a corporate leader in the pharmaceutical and biotechnology industries. Prior to assuming her position with Eyepoint Pharmaceuticals, she served as president and CEO and a director of PDI, Inc., a Nasdaq-listed healthcare commercialization company now named Interpace Diagnostics Group. She also served as senior vice president and chief marketing officer of Novartis Pharmaceuticals Corporation, the U.S. subsidiary of Novartis AG. In addition, Nancy also served as president and CEO of ImpactRx, Inc., a privately held healthcare information company. Ms. Lurker currently serves on the board of directors of the Cancer Treatment Centers of America, a privately held company. She holds a BS in Biology/Chemistry from Seattle Pacific University and an MBA in Finance/Marketing from the University of Evansville.

Year appointed: 2016

Register for this year’s Action for Impact Summit happening on September 25, 2024!